Dr. Anna Iasmine Kirkorian, M.D. Dermatology - Pediatric Dermatology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 301-718-3616 |
Lynn J. Mckinley-grant, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2041 Georgia Ave Nw Towers Building Suite 4300, Washington, DC 20060 Phone: 202-865-7504 |
Dr. Jordana Sarah Gilman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5215 Loughboro Rd Nw Ste 300, Washington, DC 20016 Phone: 410-955-5933 |
Dr. Ricardo Antonio Bullen, MD Dermatology - MOHS-Micrographic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2150 Pennsylvania Ave Nw, Second Floor, Washington, DC 20037 Phone: 202-741-2618 Fax: 202-741-2609 |
Dr. Eliot Franklin Battle Jr., M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5301 Wisconsin Ave Nw, Suite 110, Washington, DC 20015 Phone: 202-237-9292 |
Dr. Todd E Perkins, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 900 17th St Nw Ste 300, Washington, DC 20006 Phone: 202-659-2223 Fax: 202-659-0289 |
Lauren Chantel Payne, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-6100 |
Dr. Noelle Starr Sherber, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1101 15th St Nw, Suite 100, Washington, DC 20005 Phone: 202-517-7299 Fax: 202-517-7444 |
News Archive
Increases in life expectancy in the UK and elsewhere had slowed even before 2016 - and COVID-19 is expected to further eliminate any gains, Newcastle University studies show.
In the fight against super bacteria, University at Buffalo scientists are relying on strength in numbers to win the battle against drug resistance.
Using genetically engineered mice, researchers at the Johns Hopkins Children's Center have identified a gene that functions as a cancer-causing gene (or oncogene) and may play a key role in the development of leukemia and other cancers in children and adults.
Today, the U.S. Food and Drug Administration issued the final guidance, "Breast Implants - Certain Labeling Recommendations to Improve Patient Communication," as part of the agency's effort to help improve the information available to patients and health care professionals about the risks of breast implants.
› Verified 5 days ago